[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,396
Citations 0
Comment & Response
January 6, 2015

Management of Patients With Sickle Cell Disease

Author Affiliations
  • 1Department of Medicine, Albert Einstein College of Medicine, Bronx, New York
JAMA. 2015;313(1):90-91. doi:10.1001/jama.2014.15895

To the Editor The Special Communication reporting a summary of the National Heart, Lung, and Blood Institute expert panel report on the management of patients with sickle cell disease (SCD)1 distilled best practice recommendations from the extensive sickle cell anemia literature. However, the recommendation that chelation therapy should be standard for patients with SCD and iron overload failed to consider an important aspect of the problem.